The intestinal epithelium must perform two apparently opposing tasks.
It must maintain sufficient integrity to restrict uncontrolled passage from the intestinal lumen, while at the same time permitting highly regulated exchange between the external environment and the internal milieu.
One of the principal structures governing that balance is the tight junction.
Tight junctions form the most apical component of the junctional complex between neighbouring epithelial cells. They do not simply seal the space between cells. They create a dynamic, selectively permeable interface whose properties can change according to epithelial differentiation, physiological demand, immune signals, microbial products and intracellular signalling.¹–⁴
Understanding intestinal permeability therefore requires more than asking whether tight junctions are “open” or “closed”.
The more useful question is:
How is paracellular permeability regulated, and what determines what can pass between epithelial cells?
The paracellular route is selective
Molecules cross the intestinal epithelium through two broad routes.
The transcellular route passes through epithelial cells and includes highly regulated transport processes for nutrients, electrolytes and other molecules.
The paracellular route passes between adjacent epithelial cells.
Tight junctions are central regulators of this second route. Their molecular composition determines important properties of paracellular transport, including size and charge selectivity.¹–⁴
This means that paracellular permeability is not a single fixed property.
Different epithelial regions express different combinations of junctional proteins, reflecting their specialised physiological functions. The small intestine, for example, must combine barrier protection with extensive nutrient and electrolyte transport, whereas the colon operates within a dense microbial environment and has different transport requirements.
The barrier is therefore regionally specialised as well as dynamically regulated.
Claudins form the core permeability machinery
The claudin family provides much of the structural and functional basis of tight-junction permeability.
Claudins are transmembrane proteins that assemble within the membrane of one epithelial cell and interact with claudins on neighbouring cells, forming continuous tight-junction strands. Different claudin family members confer different permeability properties. Some predominantly strengthen the paracellular barrier, while others form selective paracellular channels.³–⁵
This is a critical point.
Greater tight-junction permeability is not necessarily equivalent to junctional failure.
Some claudins deliberately create selective pathways for ions and water. Paracellular transport can therefore be part of normal epithelial physiology rather than evidence of pathological leakage.
The functional state of a tight junction depends not simply on how much claudin is present, but on which claudins are expressed, where they are located, how they interact and how the junctional complex is organised.
That makes statements such as “tight-junction proteins were increased” or “claudin expression was reduced” incomplete unless the specific protein, tissue, location and functional context are known.
Occludin contributes to junctional regulation
Occludin was the first transmembrane protein identified specifically at tight junctions and remains an important component of the junctional complex.⁶
Its role, however, is not adequately described as simply “sealing” the epithelium.
Experimental evidence indicates that occludin participates in the regulation and organisation of tight junctions, including responses to signalling, cellular stress and changes in epithelial permeability. Its phosphorylation, localisation, turnover and interactions with other junctional proteins can influence barrier behaviour.²,⁶,⁷
This illustrates a broader principle of tight-junction biology:
the presence of a protein is not the same as its functional state.
Protein abundance, transcription, localisation and functional permeability are related measurements, but they are not interchangeable.
ZO proteins connect the junction to the cell
Tight-junction regulation also depends on intracellular scaffold proteins.
The zonula occludens proteins — particularly ZO-1, ZO-2 and ZO-3 — organise the junctional complex by connecting transmembrane proteins such as claudins and occludin with intracellular proteins and the actin cytoskeleton.²,³
This structural connection is fundamental because tight junctions are not independent structures sitting passively in the cell membrane.
They are mechanically and biochemically integrated with the epithelial cell.
Changes in the cytoskeleton can alter junctional organisation. Conversely, signals received at the membrane can be transmitted through scaffold proteins to intracellular pathways.
The tight junction is therefore better understood as a regulatory complex than as a molecular seal.
Pore and leak pathways are not the same
An important development in tight-junction biology has been the recognition that paracellular permeability can occur through functionally distinct routes.
The pore pathway permits selective movement of small ions and solutes. It is strongly influenced by the composition of claudin proteins and can provide physiologically regulated, charge- and size-selective transport.¹,³,⁸
The leak pathway allows passage of larger molecules and appears to involve different regulatory mechanisms, including cytoskeletal and junctional remodelling.¹,⁸
Under conditions of substantial epithelial injury, an additional unrestricted pathway may arise through epithelial discontinuities associated with cell death or tissue damage.
These mechanisms should not be collapsed into one concept of “leaky gut”.
A change in ion conductance, increased passage of a small probe and translocation of a large macromolecule may represent different biological processes.
The molecular size of the probe and the route being interrogated therefore matter when interpreting permeability experiments.
The cytoskeleton makes permeability dynamic
Tight junctions are physically connected to the perijunctional actomyosin cytoskeleton.
That connection allows epithelial permeability to respond rapidly to intracellular signalling.
One important regulatory mechanism involves myosin light-chain kinase and actomyosin contraction. Activation of this system can alter tension around the apical junctional complex and increase paracellular permeability without requiring destruction of the epithelium.⁸–¹⁰
Inflammatory mediators can engage these pathways. Tumour necrosis factor and other cytokines, for example, can influence tight-junction organisation through signalling mechanisms involving the cytoskeleton and junction-associated proteins.⁸–¹⁰
The biological meaning of increased permeability therefore depends on context.
A reversible regulatory response is not equivalent to epithelial erosion, apoptosis or structural loss.
Both may increase measured permeability.
They do not represent the same biology.
Tight junctions respond to the wider mucosal environment
Junctional regulation does not occur in isolation.
Epithelial cells continually receive signals from immune cells, microbial products, microbial metabolites, nutrients and other components of the luminal and mucosal environment. Reciprocal epithelial–immune communication is increasingly recognised as central to maintaining intestinal homeostasis.¹¹
Cytokines can modify junctional organisation and permeability.
Microbial signals can influence epithelial transcription and signalling.
Metabolites produced or modified by the microbiota can affect epithelial energy metabolism, immune responses and barrier-associated pathways.
At the same time, epithelial barrier function influences microbial spatial organisation and the degree to which luminal antigens interact with mucosal immune cells.
Tight-junction regulation is therefore embedded within a larger biological network.
This is one reason why a change in a single junctional protein rarely provides a complete account of intestinal barrier function.
Expression is not function
Barrier research frequently measures genes or proteins associated with tight junctions.
These measurements can be highly informative, particularly when identifying regulatory pathways or responses to an intervention.
But they require careful interpretation.
An increase in CLDN, OCLN or TJP transcription does not itself demonstrate reduced intestinal permeability.
Similarly, altered protein abundance does not establish how the protein is distributed within the junction or whether functional transport has changed.
This distinction is directly relevant to my own experimental work.
In zonulin-transgenic mice treated with bovine colostrum, our transcriptomic analysis identified treatment-associated changes in genes and pathways involved in tight-junction biology and inflammatory signalling, including sex-specific differences in the transcriptional response.¹²
These findings provide evidence of molecular responses relevant to barrier regulation.
They should not be translated into a claim that transcriptomic change alone proves restoration or normalisation of intestinal permeability.
That requires functional evidence at another level.
Why this matters for interpreting barrier studies
A study may report:
- altered expression of a tight-junction gene;
- redistribution of ZO-1;
- reduced transepithelial electrical resistance;
- increased molecular flux;
- increased circulating biomarker concentrations;
- or visible epithelial injury.
All may be described loosely as evidence of “barrier dysfunction”.
But they are not equivalent observations.
Each sits at a different level of the biological system.
A molecular change may indicate regulation.
A functional assay may demonstrate altered transport.
A histological finding may show structural damage.
A biomarker may be associated with one or more of these processes without measuring them directly.
The strength of the conclusion depends on preserving these distinctions.
Regulation before pathology
Tight-junction biology therefore changes how intestinal permeability should be conceptualised.
The paracellular route is not simply closed in health and open in disease.
It is continuously regulated.
Its properties emerge from the molecular composition of the junction, the cytoskeleton, intracellular signalling and the wider epithelial, immune and microbial environment.
Pathology can disrupt this system.
But permeability itself is not pathology.
The central biological question is whether selective permeability remains appropriately regulated — or whether the mechanisms governing that selectivity have become persistently or contextually dysregulated.
That distinction provides the bridge from tight-junction biology to the broader study of intestinal permeability.
References
- Turner JR. Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology. 2009;9(11):799–809. doi:10.1038/nri2653.
- Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nature Reviews Molecular Cell Biology. 2016;17(9):564–580. doi:10.1038/nrm.2016.80.
- Otani T, Furuse M. Tight junction structure and function revisited. Trends in Cell Biology. 2020;30(10):805–817. doi:10.1016/j.tcb.2020.08.004.
- Garcia-Hernandez V, Quiros M, Nusrat A. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Annals of the New York Academy of Sciences. 2017;1397(1):66–79. doi:10.1111/nyas.13360.
- Tsukita S, Tanaka H, Tamura A. The claudins: from tight junctions to biological systems. Trends in Biochemical Sciences. 2019;44(2):141–152. doi:10.1016/j.tibs.2018.09.008.
- Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. Journal of Cell Biology. 1993;123(6 Pt 2):1777–1788. doi:10.1083/jcb.123.6.1777.
- Cummins PM. Occludin: one protein, many forms. Molecular and Cellular Biology. 2012;32(2):242–250. doi:10.1128/MCB.06029-11.
- Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annual Review of Physiology. 2011;73:283–309. doi:10.1146/annurev-physiol-012110-142150.
- Clayburgh DR, Barrett TA, Tang Y, et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. Journal of Clinical Investigation. 2005;115(10):2702–2715. doi:10.1172/JCI24970.
- Weber CR, Raleigh DR, Su L, et al. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. Journal of Biological Chemistry. 2010;285(16):12037–12046. doi:10.1074/jbc.M109.064808.
- Yao Y, Shang W, Bao L, et al. Epithelial-immune cell crosstalk for intestinal barrier homeostasis. European Journal of Immunology. 2024;54(6):e2350631. doi:10.1002/eji.202350631.
- Asbjornsdottir B, Sigurdsson S, Miranda-Ribera A, et al. Evaluating prophylactic effect of bovine colostrum on intestinal barrier function in zonulin transgenic mice: a transcriptomic study. International Journal of Molecular Sciences. 2023;24(19):14730. doi:10.3390/ijms241914730.